|
Investigating the demographic characteristics of diabetic patients with COVID-19 disease admitted to Amirul Moeminin Hospital in Zabol in 2021
|
Mohammad Reza Firouzkouhi    , Arman Hossein-Zadeh , Goona Ghaderi , Esmaeil Majidi |
| Zabol University of Medical Sciences , arman.h.zadeh@gmail.com |
|
|
Abstract: (2106 Views) |
Introduction: Diabetes increases the risk of hospitalization and mortality from COVID-19 due to comorbidities. The purpose of this study was to determine the possible effects of complications related to diabetes and demographic characteristics on mortality and the duration of hospitalization of patients with COVID-19 in the hospital.
Methods: The retrospective study was conducted based on a descriptive approach. The statistical population of the study (n=130) consisted of diabetic patients hospitalized with a definite diagnosis of COVID-19 at Amirul Moeminin Ali Hospital in Zabol. The survey period was from 21 March 2021 to 21 March 2022 (one year). Data collection was done by reviewing patients' records by the researcher as well as using questionnaires and checklists.
Results: The average hospitalization time due to infection with COVID-19 was 6.5 days (7.3 days for women and 5.3 days for men). The average age of the examined people was estimated at 59.4 years (women 58.4 years and men 60.8 years). The average BMI of patients was obtained at 30.3 kg/m2 (women 30.9 kg/m2 and men 29.3 kg/m2). Out of 130 examined patients, 4 (3.1%) cases died, whose average age was 74 years. Complications of the cardiovascular system were the most common among patients. The most clinical symptoms were cough and the least was vomiting.
Conclusion: As the results of this study showed, diabetic patients who were infected with COVID-19 were exposed to a higher risk of hospitalization and more complications from this disease. Therefore, the planners of the Ministry of Health as well as nurses and personnel working in the inpatient wards of COVID-19 patients should pay more attention to these patients.
|
|
| Keywords: Coronavirus, COVID-19, Diabetes, Diabetes type 1, Diabetes type II. |
|
|
Full-Text [PDF 1129 kb]
(1463 Downloads)
|
Type of Study: Research |
Subject:
General
Received: 2023/01/21 | Accepted: 2023/01/30 | Published: 2023/05/15
|
|
|
|
|
|
|
| Send email to the article author |
|
|
|
| Add your comments about this article |
|
|
|
